BRVE logo

Braveheart Bio, Inc.

BRVE
Healthcare|Biotechnology|US
$18.60
+1.19 (+6.80%)

Ownership Breakdown

70.7M
Shares Outstanding

Major Holders (15)

Combined: 105.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Orbimed Advisors LLCInvestment adviser13.50%12,175,159Sep 10, 202613D/G
OrbiMed Capital GP IX LLCOther13.20%11,901,826Sep 10, 202613D/G
AH Bio Fund IV, L.P.Partnership11.40%10,232,420Aug 14, 202613D/G
AH Equity Partners Bio IV, L.L.C.Other11.40%10,232,420Aug 14, 202613D/G
Marc L. AndreessenIndividual11.40%10,232,420Aug 14, 202613D/G
Benjamin A. HorowitzIndividual11.40%10,232,420Aug 14, 202613D/G
FMR LLCHolding company8.20%7,374,365Nov 5, 202613D/G
Abigail P. JohnsonIndividual8.20%7,374,365Nov 5, 202613D/G
Frazier Life Sciences Public Fund, L.P.Partnership5.50%4,976,457Aug 14, 202613D/G
FHMLSP, L.P.Partnership5.50%4,976,457Aug 14, 202613D/G
FHMLSP, L.L.C.Other5.50%4,976,457Aug 14, 202613D/G
OrbiMed Genesis GP LLCOther0.30%273,333Sep 10, 202613D/G
Frazier Life Sciences XII, L.P.Partnership0.10%110,554Aug 14, 202613D/G
FHMLS Xii, L.P.Partnership0.10%110,554Aug 14, 202613D/G
FHMLS Xii, L.L.C.Other0.10%110,554Aug 14, 202613D/G

Insider Trades (59)

Last 4 quarters: 22,338,562 acquired · 35,000,000 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Agarwala VineetadirectorAug 7, 2026OTHER0——Form 4
AH Bio Fund IV, L.P.10 percent ownerAug 7, 2026BUY1,100,000$18.00$19.8MForm 4
AH Bio Fund IV, L.P.10 percent ownerAug 7, 2026CONVERSION9,132,420——Form 4
AH Bio Fund IV, L.P.10 percent ownerAug 7, 2026CONVERSION40,000,000——Form 4
Chimovits Erezdirector, 10 percent owner: Aug 7, 2026BUY1,666,667$18.00$30.0MForm 4
Chimovits Erezdirector, 10 percent owner: Aug 7, 2026CONVERSION9,132,420——Form 4
Chimovits Erezdirector, 10 percent owner: Aug 7, 2026BUY273,333$18.00$4.9MForm 4
Chimovits Erezdirector, 10 percent owner: Aug 7, 2026CONVERSION40,000,000——Form 4
ORBIMED ADVISORS LLCdirector, 10 percent owner: Aug 7, 2026BUY1,666,667$18.00$30.0MForm 4
ORBIMED ADVISORS LLCdirector, 10 percent owner: Aug 7, 2026CONVERSION9,132,420——Form 4
ORBIMED ADVISORS LLCdirector, 10 percent owner: Aug 7, 2026BUY273,333$18.00$4.9MForm 4
ORBIMED ADVISORS LLCdirector, 10 percent owner: Aug 7, 2026CONVERSION40,000,000——Form 4
Jiangsu Hengrui Pharmaceuticals Co., Ltd.10 percent ownerAug 7, 2026CONVERSION7,420,091——Form 4
Jiangsu Hengrui Pharmaceuticals Co., Ltd.10 percent ownerAug 7, 2026CONVERSION32,500,000——Form 4
Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerAug 7, 2026BUY1,920,000$18.00$34.6MForm 4
Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerAug 7, 2026BUY1,680,000$18.00$30.2MForm 4
Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerAug 7, 2026CONVERSION9,132,420——Form 4
Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerAug 7, 2026CONVERSION7,990,867——Form 4
Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerAug 7, 2026CONVERSION35,000,000——Form 4
Rickey James PaulChief Financial OfficerAug 7, 2026BUY27,777$18.00$500.0KForm 4
Rickey James PaulChief Financial OfficerAug 5, 2026AWARD300,000$18.00$5.4MForm 4
Lohoff TimdirectorAug 5, 2026AWARD30,000$18.00$540.0KForm 4
Chimovits Erezdirector, 10 percent owner: Aug 5, 2026AWARD30,000$18.00$540.0KForm 4
Viehbacher ChristopherdirectorAug 7, 2026BUY83,333$18.00$1.5MForm 4
Viehbacher ChristopherdirectorAug 5, 2026AWARD30,000$18.00$540.0KForm 4
Malek David IdirectorAug 7, 2026BUY4,166$18.00$75.0KForm 4
Malek David IdirectorAug 5, 2026AWARD30,000$18.00$540.0KForm 4
Anderson Michele A.Chief Development OfficerAug 7, 2026BUY1,111$18.00$20.0KForm 4
Anderson Michele A.Chief Development OfficerAug 5, 2026AWARD300,000$18.00$5.4MForm 4
Murdoch Travisdirector, officer: CEO and PresidentAug 7, 2026BUY83,333$18.00$1.5MForm 4
Murdoch Travisdirector, officer: CEO and PresidentAug 5, 2026AWARD550,000$19.80$10.9MForm 4
Bos JasperdirectorAug 5, 2026AWARD30,000$18.00$540.0KForm 4
Lubner David CharlesdirectorAug 5, 2026AWARD60,000$18.00$1.1MForm 4
Lubner David CharlesdirectorAug 7, 2026BUY55,555$18.00$1000.0KForm 4
Jiangsu Hengrui Pharmaceuticals Co., Ltd.10 percent ownerAug 5, 2026OTHER7,420,091——Form 4
ORBIMED ADVISORS LLCdirector, 10 percent owner: Aug 5, 2026OTHER0——Form 4
ORBIMED ADVISORS LLCdirector, 10 percent owner: Aug 5, 2026OTHER9,132,420——Form 4
AH Bio Fund IV, L.P.10 percent ownerAug 5, 2026OTHER9,132,420——Form 4
Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerAug 5, 2026OTHER0——Form 4
Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerAug 5, 2026OTHER0——Form 4
Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent ownerAug 5, 2026OTHER7,990,867——Form 4
Rickey James PaulChief Financial OfficerAug 5, 2026OTHER0——Form 4
Rickey James PaulChief Financial OfficerAug 5, 2026OTHER0——Form 4
Viehbacher ChristopherdirectorAug 5, 2026OTHER0——Form 4
Viehbacher ChristopherdirectorAug 5, 2026OTHER0——Form 4
Bos Jasperdirector: Aug 5, 2026OTHER0——Form 4
Lubner David Charlesdirector: Aug 5, 2026OTHER0——Form 4
Anderson Michele A.Chief Development OfficerAug 5, 2026OTHER0——Form 4
Anderson Michele A.Chief Development OfficerAug 5, 2026OTHER70,776$3.07$217.3KForm 4
Chimovits Erezdirector, 10 percent owner: Aug 5, 2026OTHER0——Form 4
Chimovits Erezdirector, 10 percent owner: Aug 5, 2026OTHER9,132,420——Form 4
Murdoch Travisdirector, 10 percent owner, officer: CEO and PresidentAug 5, 2026OTHER0——Form 4
Murdoch Travisdirector, 10 percent owner, officer: CEO and PresidentAug 5, 2026OTHER0——Form 4
Murdoch Travisdirector, 10 percent owner, officer: CEO and PresidentAug 5, 2026OTHER0——Form 4
Lohoff Timdirector: Aug 5, 2026OTHER0——Form 4
Malek David IdirectorAug 5, 2026OTHER0——Form 4
Malek David IdirectorAug 5, 2026OTHER0——Form 4
Coloma Jason VdirectorAug 5, 2026OTHER0——Form 4
Coloma Jason VdirectorAug 5, 2026OTHER0——Form 4